Cargando…

Novel pharmacologic treatment in acute binge eating disorder – role of lisdexamfetamine

Binge eating disorder (BED) is the most common eating disorder and an important public health problem. It is characterized by recurrent episodes of excessive food consumption accompanied by a sense of loss of control over the binge eating behavior without the inappropriate compensatory weight loss b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guerdjikova, Anna I, Mori, Nicole, Casuto, Leah S, McElroy, Susan L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841437/ https://www.ncbi.nlm.nih.gov/pubmed/27143885 http://dx.doi.org/10.2147/NDT.S80881

Ejemplares similares

Pharmacological management of binge eating disorder: current and emerging treatment options
por: McElroy, Susan L, et al.
Publicado: (2012)

Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase 3 Randomized Controlled Trials
por: McElroy, Susan L, et al.
Publicado: (2016)

A Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults With Binge Eating Disorder
por: Gasior, Maria, et al.
Publicado: (2017)

Time course of the effects of lisdexamfetamine dimesylate in two phase 3, randomized, double‐blind, placebo‐controlled trials in adults with binge‐eating disorder
por: McElroy, Susan L., et al.
Publicado: (2017)

The Cost Effectiveness of Lisdexamfetamine Dimesylate for the Treatment of Binge Eating Disorder in the USA
por: Ágh, Tamás, et al.
Publicado: (2016)

Impulsivity and Its Relationship With Lisdexamfetamine Dimesylate Treatment in Binge Eating Disorder
por: Griffiths, Kristi R., et al.
Publicado: (2021)

Concurrent Improvement in Both Binge Eating and Depressive Symptoms with Naltrexone/Bupropion Therapy in Overweight or Obese Subjects with Major Depressive Disorder in an Open-Label, Uncontrolled Study
por: Guerdjikova, Anna I., et al.
Publicado: (2017)

A matter of time: A systematic scoping review on a potential role of the circadian system in binge eating behavior
por: Romo-Nava, Francisco, et al.
Publicado: (2022)

An exploratory machine learning approach to identify placebo responders in pharmacological binge eating disorder trials
por: Goyal, Rahul K., et al.
Publicado: (2022)

A psychometric analysis and revalidation of the Yale-Brown Obsessive Compulsive Scale modified for Binge Eating in adults with binge eating disorder
por: Yee, Karen, et al.
Publicado: (2019)

Use of Lisdexamfetamine to Treat Obesity in an Adolescent with Severe Obesity and Binge Eating
por: Srivastava, Gitanjali, et al.
Publicado: (2019)

Evaluation of the role of lisdexamfetamine on attention-deficit/hyperactivity disorder common psychiatric comorbidities: mechanistic insights on binge eating disorder and depression
por: Gutiérrez Casares, J.R., et al.
Publicado: (2022)

In silico evaluation of the role of lisdexamfetamine on attention-deficit/hyperactivity disorder common psychiatric comorbidities: mechanistic insights on binge eating disorder and depression
por: Gutiérrez-Casares, José Ramón, et al.
Publicado: (2023)

Understanding the neural mechanisms of lisdexamfetamine dimesylate (LDX) pharmacotherapy in Binge Eating Disorder (BED): a study protocol
por: Griffiths, Kristi R., et al.
Publicado: (2019)

Evaluating functional disability in clinical trials of lisdexamfetamine dimesylate in binge eating disorder using the Sheehan Disability Scale
por: Yee, Karen S., et al.
Publicado: (2020)

An Innovative Disease‐Drug‐Trial Framework to Guide Binge Eating Disorder Drug Development: A Case Study for Topiramate
por: Kalaria, Shamir N., et al.
Publicado: (2019)

The effects of lisdexamfetamine dimesylate on eating behaviour and homeostatic, reward and cognitive processes in women with binge-eating symptoms: an experimental medicine study
por: Schneider, Elizabeth, et al.
Publicado: (2022)

Efficacy and safety of dasotraline in adults with binge-eating disorder: a randomized, placebo-controlled, fixed-dose clinical trial
por: Grilo, Carlos M., et al.
Publicado: (2021)

Lisdexamfetamine in the treatment of moderate-to-severe binge eating disorder in adults: systematic review and exploratory meta-analysis of publicly available placebo-controlled, randomized clinical trials
por: Fornaro, Michele, et al.
Publicado: (2016)

The Role of the Endocannabinoid System in Binge Eating Disorder
por: Bourdy, Romain, et al.
Publicado: (2023)

Emotional eating across different eating disorders and the role of body mass, restriction, and binge eating
por: Reichenberger, Julia, et al.
Publicado: (2021)

Bipolar disorder with binge eating behavior: a genome-wide association study implicates PRR5-ARHGAP8
por: McElroy, Susan L., et al.
Publicado: (2018)

Examining emotion regulation in binge-eating disorder
por: Walenda, Anna, et al.
Publicado: (2021)

Oleoylethanolamide decreases frustration stress-induced binge-like eating in female rats: a novel potential treatment for binge eating disorder
por: Romano, Adele, et al.
Publicado: (2020)

Secondary outcomes and qualitative findings of an open-label feasibility trial of lisdexamfetamine dimesylate for adults with bulimia nervosa
por: Dixon, Laura, et al.
Publicado: (2023)

Naltrexone/Bupropion Combination Therapy in Overweight or Obese Patients With Major Depressive Disorder: Results of a Pilot Study
por: McElroy, Susan L., et al.
Publicado: (2013)

Placebo response in binge eating disorder
por: Jacobs-Pilipski, M Joy, et al.
Publicado: (2007)

Psychofarmacological approach for Binge- eating disorders
por: Muñoz Martinez, V., et al.
Publicado: (2022)

Is the binge-eating disorder a circadian disorder?
por: Plano, Santiago A., et al.
Publicado: (2022)

Correction: Secondary outcomes and qualitative findings of an open-label feasibility trial of lisdexamfetamine dimesylate for adults with bulimia nervosa
por: Dixon, Laura, et al.
Publicado: (2023)

Health-Related Quality of Life in Obese Presurgery Patients with and without Binge Eating Disorder, and Subdiagnostic Binge Eating Disorders
por: Sandberg, Rita Marie, et al.
Publicado: (2013)

Peripheral Endocannabinoid Responses to Hedonic Eating in Binge-Eating Disorder
por: Monteleone, Alessio Maria, et al.
Publicado: (2017)

Psychological, pharmacological, and combined treatments for binge eating disorder: a systematic review and meta-analysis
por: Ghaderi, Ata, et al.
Publicado: (2018)

Antecedent life events of binge-eating disorder
por: Pike, Kathleen M., et al.
Publicado: (2006)

Binge eating disorder during COVID-19
por: Mumtaz, Sara, et al.
Publicado: (2022)

Binge eating disorders in the age of coronavirus outbreak
por: Dhemaid, M., et al.
Publicado: (2021)

Comparison of binge-eating disorder and food addiction
por: Ratković, Dragana, et al.
Publicado: (2023)

Clinical aspects of binge eating disorder: A cross-sectional mixed-methods study of binge eating disorder experts' perspectives
por: Bray, Brenna, et al.
Publicado: (2023)

Mental health aspects of binge eating disorder: A cross-sectional mixed-methods study of binge eating disorder experts' perspectives
por: Bray, Brenna, et al.
Publicado: (2022)

Validation of the Arabic version of the binge eating scale and correlates of binge eating disorder among a sample of the Lebanese population
por: Zeidan, Rouba Karen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uv3kp1kdllcm81u78h7fmdjp88